⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11797832 | 0.63 | — | — | |
| SCHEMBL9384920 | 0.60 | — | — | |
| SCHEMBL6993877 | 0.51 | — | — | |
| SCHEMBL180417 | 0.51 | — | — | |
| SCHEMBL3188857 | 0.51 | — | — | |
| SCHEMBL11349435 | 0.48 | — | — | |
| SCHEMBL388298 | 0.44 | — | — | |
| SCHEMBL11204917 | 0.38 | — | — | |
| SCHEMBL2704746 | 0.38 | — | — | |
| SCHEMBL186926 | 0.38 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3524608-B1 | NOVEL PYRIMIDINE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION USING SAME | SPARK BIOPHARMA INC (KR) | 2020-12-30 | — | — | EP | disclosed |